12 Biggest Mid-Day Losers For Monday

  • Aralez Pharmaceuticals Inc ARLZ shares dipped 27 percent to $2.58 after the company posted a wider-than-expected quarterly loss.
  • Cerecor Inc CERC shares fell 21.7 percent to $0.940. Cerecor shares have dropped 73.03 percent over the past 52 weeks, while the S&P 500 index has gained 17.48 percent in the same period.
  • Catabasis Pharmaceuticals Inc CATB shares declined 18.6 percent to $1.66. Catabasis Pharmaceuticals disclosed that it will present data from Part B of the MoveDMD trial of edasalonexent at the 2017 Muscular Dystrophy Association Scientific Conference.
  • Nobilis Health Corp (USA) HLTH shares dropped 14 percent to $1.70 after the company reported downbeat results for its fourth quarter.
  • ParkerVision, Inc. PRKR shares tumbled 13.6 percent to $2.28. ParkerVision disclosed that it is filing a motion to terminate its ITC investigation after ruling to disallow key evidence for '528 patent.
  • Sunworks Inc SUNW shares declined 13 percent to $1.48 after the company issued a weak sales forecast.
  • Osiris Therapeutics, Inc. OSIR shares dropped 8.8 percent to $4.74 after dropping 4.24 percent on Friday. Osiris disclosed that it has received notice of delisting from the NASDAQ on Friday.
  • Patriot National Inc PN fell 8.5 percent to $3.13. JMP Securities downgraded Patriot National from Market Outperform to Market Perform.
  • Silver Spring Networks Inc SSNI slipped 4.6 percent to $10.62. Williams Financial downgraded Silver Spring Networks from Buy to Hold.
  • Medgenics Inc GNMX shares dropped 5.8 percent to $5.70 after surging 12.24 percent on Friday.
  • Zosano Pharma Corp ZSAN shares dropped 5.5 percent to $2.22 after declining 1.67 percent on Friday.
  • GameStop Corp. GME shares fell around 3 percent to $24.52. Telsey Advisory Group downgraded GameStop from Outperform to Market Perform.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!